Form 8-K - Current report:
SEC Accession No. 0001683168-25-004952
Filing Date
2025-07-07
Accepted
2025-07-07 16:15:26
Documents
14
Period of Report
2025-07-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aclarion_8k.htm   iXBRL 8-K 34506
2 PRESS RELEASE aclarion_ex9901.htm EX-99.1 7713
  Complete submission text file 0001683168-25-004952.txt   257295

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE acon-20250707.xsd EX-101.SCH 3787
4 XBRL DEFINITION FILE acon-20250707_def.xml EX-101.DEF 26647
5 XBRL LABEL FILE acon-20250707_lab.xml EX-101.LAB 36764
6 XBRL PRESENTATION FILE acon-20250707_pre.xml EX-101.PRE 25271
16 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 251108194
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)